InVivo Therapeutics Holdings Corporation(NASDAQ : NVIV)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.62% | 190.36 | 1.2% | $564.46m | |
| GILD | Gilead Sciences, Inc. | -0.52% | 70.55 | 0.9% | $491.72m | |
| BIIB | Biogen Inc. | -1.73% | 313.55 | 1.3% | $448.17m | |
| CELG | Celgene Corporation | -0.87% | 69.63 | 1.2% | $426.13m | |
| ILMN | Illumina, Inc. | -0.95% | 308.23 | 3.5% | $394.71m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.41% | 337.29 | 2.6% | $283.70m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -3.36% | 164.58 | 1.9% | $265.75m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.03% | 116.11 | 2.0% | $195.76m | |
| A | Agilent Technologies, Inc. | -1.32% | 63.49 | 1.5% | $175.37m | |
| EXAS | Exact Sciences Corporation | -1.38% | 68.45 | 25.3% | $145.96m | |
| LGND | Ligand Pharmaceuticals Incorporated | -0.42% | 147.80 | 23.3% | $142.63m | |
| SRPT | Sarepta Therapeutics, Inc. | -4.09% | 111.99 | 16.4% | $134.89m | |
| ECYT | Endocyte, Inc. | -0.21% | 23.53 | 2.0% | $121.26m | |
| INCY | Incyte Corporation | 0.66% | 64.15 | 2.5% | $116.78m | |
| NKTR | Nektar Therapeutics | 0.80% | 37.65 | 5.6% | $109.74m |
Company Profile
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of SCIs. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in 2005 and is headquartered in Cambridge, MA.